Equity
€361,982 ▲ 33.5%
DOCTEUR VUCKOVIC has made a profit in every financial year since 2021.
DOCTEUR VUCKOVIC
Lifetime
5 annual accounts with figures on one time axispeak €157,624 (2025)
€157,624▲ 0.6%
peak €96,261 (2024)
€90,752▼ 5.7%
peak €361,982 (2025)
€361,982▲ 33.5%
€146,652▼ 17.7%
Board2 names since 2020
2 directorsCatherine HALLUENT and 1 other
Documentsfilings and deeds
30-09-202661 days late
2025micro format
Equity from €271,230 to €361,982Debts from €178,257 to €146,652Cash from €112,390 to €324,034
Key points
from the 2025 annual accountsChecked score
95
Excellent
Financially stronger than 63% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: 0.1%▲ +0.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.2%▲ +0.1 percentage points vs 09-2025
11-2025: 0.3%▲ +0.1 percentage points vs 10-2025highest value
12-2025: 0.1%▼ -0.2 percentage points vs 11-2025
01-2026: < 0.1%▼ -0.1 percentage points vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: 0.1%▲ +0.1 percentage points vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.2%▲ +0.1 percentage points vs 08-2026
10-2026: < 0.1%▼ -0.2 percentage points vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Last filed accounts filed 61 days late; 2 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 2.29, cash €324,034
Size: total assets €508,634
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 59% of them on solvency, 72% on liquidity, 47% on profitability and 73% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,782 companies had the same profile as DOCTEUR VUCKOVIC has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
That fits the bankruptcy probability of DOCTEUR VUCKOVIC itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,782 companies, not a prediction for DOCTEUR VUCKOVIC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.29 (1.51 in 2024), above the usual 1.5. Short-term debt is 28.8% and cash 63.7% of total assets. 28.8% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 61 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-09-2026, 61 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 5 filingsDeviation from the deadline
2025
61 days late
2024
95 days late
2023
29 days late
2022
18 days late
2021
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 5 accounts on average 47 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0760516919
First establishment
Rue Sainte Famille 23, Pont-à-Celles
Incorporation
Founding capital of €6,200, 100 shares · Founder: Michel VUCKOVIC · Appointments: Michel VUCKOVIC (director) and Catherine HALLUENT (director) · published on 29-12-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DOCTEUR VUCKOVIC Pont-à-Celles | €508,634 | €157,624 | 71.2% | - |
| Docteur Sarah PIRON Stavelot | €497,589 | €149,847 | 51.6% | - |
| Médi-Engis Engis | €537,262 | €150,886 | -5.5% | - |
| Dr. Pieter Van Ranst, huisarts Sint-Niklaas | €459,442 | €153,918 | 97.2% | - |
| Dr. E. Deforche Zonnebeke | €471,475 | €152,622 | 58.3% | - |
| Dokter Mohamed Ghazal Antwerp | €525,138 | €145,390 | 36.7% | - |
| DOKTER LORE VERSTRAETE Roeselare | €474,088 | €161,681 | 62.8% | - |
These companies have the same main activity as DOCTEUR VUCKOVIC: general medical practice (NACE 86210). They are comparable in size and age: total assets between €459,000 and €537,000, founded between 2020 and 2021.
Official details
Source: KBO- Status
- Active since 24-12-2020Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.311.166.1446230 Pont-à-Celles, since 29-12-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 18-12-2025
Insights on DOCTEUR VUCKOVIC
DOCTEUR VUCKOVIC files the micro format. That format states no turnover. The gross margin rose from €87,354 in 2021 to €157,624 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DOCTEUR VUCKOVIC
- What is the company number of DOCTEUR VUCKOVIC?
- The company number of DOCTEUR VUCKOVIC is 0760.516.919. The VAT number is the same number with BE in front: BE 0760.516.919.
- Where is DOCTEUR VUCKOVIC based?
- The registered office is at Rue Sainte Famille 23, 6230 Pont-à-Celles.Company details
- What does DOCTEUR VUCKOVIC do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of DOCTEUR VUCKOVIC?
- DOCTEUR VUCKOVIC is a private limited company (BV).
- When was DOCTEUR VUCKOVIC founded?
- DOCTEUR VUCKOVIC was founded on 24-12-2020.
- Is DOCTEUR VUCKOVIC still active?
- Yes, DOCTEUR VUCKOVIC is an active enterprise in the KBO register.
- What is the turnover of DOCTEUR VUCKOVIC?
- The turnover in financial year 2025 is ≈ €320,000. This figure is estimated from the gross margin of €157,624 and 65 comparable companies (NACE 862). It probably lies between €240,000 and €400,000.Financials
- Is DOCTEUR VUCKOVIC profitable?
- In financial year 2025, DOCTEUR VUCKOVIC made a profit of €90,752.
- Where can I find the annual accounts of DOCTEUR VUCKOVIC?
- DOCTEUR VUCKOVIC filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DOCTEUR VUCKOVIC due?
- DOCTEUR VUCKOVIC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.